MDSpire - Takeaway
Commentary & Perspectives

Limits of Negative Infection Studies in AD

Perspective argues that study design and measurement challenges may obscure potential links between infection and disease

Share

  • 1

    HSV-1 is widely carried but not linked to Alzheimer's in most cases.

  • 2

    Studies dismissing infection links may lack proper design.

  • 3

    Serum antibody levels may not reflect CNS conditions.

  • 4

    Genetic interactions may play a role in Alzheimer's.

  • 5

    Future studies should refine measurement of infections.

  • 6

    No current treatment suggests Alzheimer's as an active infection.

  • 7

    Further understanding of pathogenic effects is needed.

Original Source(s)

Limits of Negative Infection Studies in AD

  • by Kerri Miller

  • March 26, 2026

Related Content

Non-Invasive HIFU Treatment Transforms Care for Essential Tremor Patients

The uncontrolled shaking in his hands was caused by a neurological condition known as essential tremor (ET), which affects approximately one in 300 people.

  • by

  • March 26, 2026

  • 8 min
Tau Biomarker Expands Beyond Alzheimer’s

Study finds elevated phosphorylated tau in AL and ATTR amyloidosis, suggesting a potential blood biomarker for amyloid-related neuropathy

  • March 25, 2026

  • 3 min
CAR-Engineered Astrocytes in Alzheimer’s Models

Preclinical findings show engineered astrocytes reduce amyloid buildup in mouse models and demonstrate a potential therapeutic approach

  • March 25, 2026

  • 2 min